Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
The Evolving Landscape of HIV Drug Resistance Diagnostics for Expanding Testing in Resource-Limited Settings.
A21 HIV-1 sub-subtype F1 outbreak among MSM in Belgium.
Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers.
Interferon-γ-Inducible Protein 10 (IP-10) as a Screening Tool to Optimize Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings.
Deep sequencing for HIV-1 clinical management.
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.
Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants.
A Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep Pyrosequencing.
Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study.
Treatment options after virological failure of first-line tenofovir-based regimens in South Africa: an analysis by deep sequencing.